Breaking News2 years ago
New Treatment for Moderate to Severe Atopic Dermatitis Shows Promising Long-Term Results
[ad_1] Newswise — Patients with moderate to severe atopic dermatitis who participated in a clinical trial of rocatinlimab—a novel, patient-tailored monoclonal antibody therapy—showed promising results both...